相关实验视频

Updated: May 6, 2026

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

分层分析完善了TLR7罕见变体和严重的COVID-19之间的关联

Jannik Boos¹, Caspar I van der Made², Gayatri Ramakrishnan³

¹Institute of Human Genetics, University of Bonn School of Medicine and University Hospital Bonn, Bonn, Germany.

|June 30, 2024

概括

在TLR7基因的罕见遗传变异显著增加严重的COVID-19的风险,特别是在没有其他风险因素的年轻人. 这一发现突显了TLR7在对病毒的免疫反应中的作用.

科学领域:

遗传学遗传学是一个
免疫学免疫学免疫学
传染性疾病传染性疾病

背景情况:

对严重的COVID-19的遗传倾向正在进行广泛的研究.
罕见宿主遗传变异的作用及其与其他风险因素的相互作用需要进一步阐明.

研究的目的:

研究52个候选基因中的罕见遗传变异与严重的COVID-19之间的关联.
完善对严重的COVID-19病原体中的Toll-like受体7 (TLR7) 变体的理解.

主要方法:

在1,772例严重的COVID-19病例和5,347例来自西班牙和意大利的对照中测序了52种病因基因.
对罕见有害TLR7变体的分析,包括功能测试和蛋白质建模以评估效应大小.
在仅为女性的子组中检查X染色体基因关联.

主要成果:

罕见有害的TLR7变种在2.4%的年轻,健康的严重COVID-19病例中被发现,而对照组的0.24% (OR=12.3,p=1.27×10−10).
功能测试和蛋白质建模将TLR7变异的几率比率提高到46.5 (p=1.74×10−15).
在女性中观察到TLR7的关联信号,表明复杂的遗传模式.

结论:

罕见的TLR7变种是严重COVID-19的重要遗传风险因素,特别是在年轻人中.
证据支持干扰素信号通路基因 (TLR7,IFNAR2,IFIH1,TBK1) 在严重的COVID-19中参与.
这些发现有助于理解严重的COVID-19和宿主-病原体相互作用的遗传结构.

关键词:

这就是SARS-CoV-2病毒.负担分析负担分析主体遗传学主体遗传学免疫缺陷免疫缺陷免疫缺陷感染的感染感染.这是先天免疫力.罕见的变种罕见的变种有针对性的测序.收费类受体 7 的收费类受体变种的崩分析.

更多相关视频

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

相关概念视频

Single Nucleotide Polymorphisms-SNPs

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...